Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomised, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending and Repeated Doses of Orally Administered ZF874 in Healthy Volunteers and PiXZ Subjects

NCT04443192 is registered in ClinicalTrials.gov with Z Factor Limited as lead sponsor.

NCT NCT04443192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04443192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomised, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending and Repeated Doses of Orally Administered ZF874 in Healthy Volunteers and PiXZ Subjects
Lead sponsor
Z Factor Limited
Phase
Phase 1
Overall status
Terminated
Start date
August 3, 2020
Completion date
September 12, 2022
Enrollment
69 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

alpha1 anti-trypsin deficiency